REGN
REGENERON PHARMACEUTICALS
CUSIP: 75886F107
REGENERON PHARMACEUTICALS (REGN) — institutional ownership and SEC 13F holdings data. Healthcare sector. Source: SEC EDGAR 13F filings.
About
Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. The company is known for its expertise in monoclonal antibodies and maintains a diverse portfolio focused on ophthalmology, oncology, and inflammatory diseases. Regeneron holds a significant market position through key products like Eylea and Dupixent, which are established leaders in their respective therapeutic areas.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...